Actively Recruiting

Phase Not Applicable
Age: 16Years +
All Genders
Healthy Volunteers
ID06422793

The Impact of Nasogastric Tube Gastric Decompression on Postoperative Nausea and Vomiting in Orthognathic Surgery

Led by Nova Scotia Health Authority · Updated on 2025-01-14

92

Participants Needed

1

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to compare the occurrence of nausea and vomiting within the first 24 hours after corrective jaw surgery, known as orthognathic surgery. It focuses on patients undergoing this surgery and evaluates how using a nasogastric (NG) tube for stomach decompression during and shortly after surgery may affect these symptoms. The study also considers other factors such as anesthesia type, surgery length, surgery type, and patient characteristics that might influence nausea and vomiting. Participants will be randomly assigned to one of two groups. One group will not have an NG tube inserted during surgery, while the other group will receive NG tube gastric decompression following a specific protocol. For the decompression group, a tube will be inserted after anesthesia and connected to suction to remove stomach contents during surgery and for one hour after surgery. The tube will then be removed. Both groups will otherwise receive the same surgical care. During the study, participants will be monitored for nausea and vomiting at two time points: early (0 to 2 hours after surgery) and delayed (2 to 24 hours after surgery). Researchers will document any complications related to the NG tube and assess various factors that might impact nausea and vomiting. The study will use patient assessments and surgical records to measure outcomes, with participation lasting through the immediate 24-hour postoperative period.

CONDITIONS

Brief Title

The Impact of Nasogastric Tube Gastric Decompression on Postoperative Nausea and Vomiting in Orthognathic Surgery

Who Can Participate

Age: 16Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over the age of 16 at the time of consent undergoing orthognathic surgery for correction of dentofacial deformities during the study period.
  • Patients receiving single-jaw surgery (Bilateral Sagittal Split Osteotomy only or LeFort only).
  • Patients receiving double-jaw surgery (Bilateral Sagittal Split Osteotomy and LeFort).
  • Patients undergoing a functional genioplasty in addition to another osteotomy (Bilateral Sagittal Split Osteotomy and/or LeFort).
Not Eligible

You will not qualify if you...

  • Patients under the age of 16 at the time of consent.
  • Patients contraindicated to undergo elective surgery, including pregnant patients.
  • Patients undergoing a functional genioplasty procedure only.
  • Patients taking GLP-1 receptor agonists.
  • Patients with known gastroparesis.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Surgery day and 1 hour postoperatively

Participants undergo orthognathic surgery with or without nasogastric tube gastric decompression during surgery and up to one hour postoperatively.

1 surgical visit and 1 immediate post-operative observation

Post-operative Follow-up

Duration - 24 hours postoperatively

Participants are monitored for early and delayed postoperative nausea and vomiting up to 24 hours after surgery.

2 assessments (0-2 hours and 2-24 hours postoperatively)

Trial Site Locations

Total: 1 location

1

Victoria General Hospital

Halifax, Nova Scotia, Canada, B3H 2Y9

Actively Recruiting

Loading map...

Research Team

K

Katherine A Curry, DDS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Advancing Strategies to Optimize the PerIopeRativE Managemen...

Postoperative Nausea

Actively Recruiting

1 location

Comparison of Remimazolam Alone, Propofol Alone, and Their C...

Postoperative Complications

Actively Recruiting

1 location

Intraoperative Autonomic Blockade to Prevent Early Postopera...

Visceral Pain

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Incidence and risk factors for postoperative nausea and vomiting in orthognathic surgery: a 10-year retrospective study.

Subhabrata Ghosh, Kirthi Kumar Rai, Hosadurga Rudraswamy Shivakumar...

https://pubmed.ncbi.nlm.nih.gov/32364351

Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Weixia Zhong, Omar Shahbaz, Garrett Teskey...

https://pubmed.ncbi.nlm.nih.gov/34071460

Postoperative nausea and vomiting (PONV) after orthognathic surgery: a retrospective study and literature review.

Alessandro C Silva, Felice O'Ryan, David B Poor

https://pubmed.ncbi.nlm.nih.gov/16916674